Navigation Links
Texas Children's Cancer Center first in Texas to magnetically lengthen nine-year-old's leg as she grows
Date:4/15/2010

HOUSTON (April 15, 2010) -- Nine-year-old Morgan LaRue is the first cancer patient in Texas to benefit from a groundbreaking procedure that will magnetically lengthen her leg, sparing her the possibility of up to 10 future surgeries as her body grows. The implant and extension took place at Texas Children's Cancer Center in Houston, Texas. To learn more about Texas Children's Cancer Center or the device, please see http://bit.ly/MorganLaRue.

On March 29, 2010, Morgan lost a portion of the bone in her upper leg to osteosarcoma (bone cancer) and was facing the potential of numerous surgeries in order to keep her left leg even with her right, as she grows into adulthood. In her initial surgery two weeks ago, Dr. Rex Marco, an oncologic orthopedic surgeon at Texas Children's Hospital and the University of Texas Health Science Center at Houston, implanted a prosthetic device that saved Morgan from a lower limb amputation and allowed her cancerous bone to be replaced with a metal implant. The device, a Stanmore Implants Extendable Distal Femoral Replacement, can be extended as Morgan grows, saving her from ongoing invasive procedures.

This week at Texas Children's Cancer Center, Morgan underwent her first outpatient procedure to magnetically extend her leg. By placing her leg into a magnetized "donut" in the outpatient clinic, doctors were able to extend the implanted prosthesis without having to do any surgery. The magnet extender, manufactured by Stanmore Implants, is a reversible extender that is the first and only device of its kind to be used in Texas.

"The difference this device makes for Morgan is incredible," said Dr. Marco. "Her quality of life is so much higher than it would be if she were constantly undergoing surgery."

While the device has been approved and is regularly being used in Europe, it is still pending U. S. Food and Drug Administration approval and has only been used for approximately 15 patients in this country. Dr. Wang, pediatric oncologist at Texas Children's Cancer Center and Assistant Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, and Dr. Marco, advocated for and received a "compassionate use" exception for the young girl, in order to implant the groundbreaking device. "Morgan has already been through a lot of treatment for her cancer," said Dr. Wang, Morgan's oncologist, "and this will prevent her from future uncomfortable surgeries."


'/>"/>

Contact: Carol Wittman
cmwittma@texaschildrens.org
832-824-2040
Texas Children's Hospital
Source:Eurekalert

Related biology news :

1. UT Southwesterns BioCenter driving biotech, medical innovation in North Texas
2. Biogas technology with potential to save thousands of lives to be featured at Texas event
3. Quickly and easily integrate fingerprint biometric features into portable applications with Texas Instruments comprehensive, low cost fingerprint development kit
4. Texas Childrens discharges history-making patient
5. University of Texas Southwestern Medical Center researcher wins Avanti Award in lipids
6. Texas AgriLife researchers helping
7. Texas A&M Researchers Examine How Viruses Destroy Bacteria
8. UT Southwestern patient first in North Texas to receive newest-generation heart failure device
9. Texas A&M researchers find new mechanism for circadian rhythm
10. Texas A&M oceanographer receives $3.7 million grant to study Gulf dead zone
11. More than half of Texas physicians do not always recommend HPV vaccine to girls
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/26/2017)... 2017  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announces the appointment ... "Too often, too many offenders return to ... are trying to tackle this ongoing problem and ... family members. While significant steps are underway, Securus continues ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017 Sinovac Biotech Ltd. ("Sinovac" or ... China , today announced that its board of ... date of the plan from March 27, 2017 to March 27, ... About Sinovac Biotech Ltd. ... Sinovac Biotech Ltd. is a ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... exhibits both viscous and elastic characteristics when deformed, which is identical to how ... to gently absorb compressive forces and return to its natural state along a ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
Breaking Biology Technology: